Healthcare provider profile · identity verified

James C. Scheer, DO

Family Practice · CONCORD, NC · NPI 1326100389

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	307	82
Rosuvastatin Calcium	Rosuvastatin Calcium	253	68
Atorvastatin Calcium	Atorvastatin Calcium	222	62
Lisinopril	Lisinopril	195	62
Amlodipine Besylate	Amlodipine Besylate	178	56
Omeprazole	Omeprazole	178	49
Gabapentin	Gabapentin	176	43
Losartan Potassium	Losartan Potassium	165	51
Hydrochlorothiazide	Hydrochlorothiazide	153	47
Trazodone Hcl	Trazodone Hcl	147	37
Metoprolol Succinate	Metoprolol Succinate	130	35
Duloxetine Hcl	Duloxetine Hcl	121	20
Alprazolam	Alprazolam	109	19
Metformin Hcl Er	Metformin Hcl	103	24
Montelukast Sodium	Montelukast Sodium	101	26
Potassium Chloride	Potassium Chloride	100	18
Clonazepam	Clonazepam	99	16
Glipizide Er	Glipizide	95	22
Tramadol Hcl	Tramadol Hcl	91	22
Pantoprazole Sodium	Pantoprazole Sodium	83	20
Metformin Hcl	Metformin Hcl	82	20
Eliquis	Apixaban	80	16
Bupropion Xl	Bupropion Hcl	73	20
Fluticasone Propionate	Fluticasone Propionate	69	18
Sertraline Hcl	Sertraline Hcl	65	15
Tizanidine Hcl	Tizanidine Hcl	64	15
Furosemide	Furosemide	62	16
Albuterol Sulfate Hfa	Albuterol Sulfate	58	16
Buspirone Hcl	Buspirone Hcl	58	14
Pravastatin Sodium	Pravastatin Sodium	53	16
Atenolol	Atenolol	52	15
Celecoxib	Celecoxib	52	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	52	16
Diazepam	Diazepam	49	14
Metoprolol Tartrate	Metoprolol Tartrate	47	16
Zolpidem Tartrate	Zolpidem Tartrate	47	12
Venlafaxine Hcl Er	Venlafaxine Hcl	45	12
Warfarin Sodium	Warfarin Sodium	45	suppressed
Clopidogrel	Clopidogrel Bisulfate	43	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	43	suppressed
Ezetimibe	Ezetimibe	43	14
Fluconazole	Fluconazole	42	18
Carvedilol	Carvedilol	41	15
Ozempic	Semaglutide	40	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	40	14
Fluoxetine Hcl	Fluoxetine Hcl	35	11
Baclofen	Baclofen	34	14
Meloxicam	Meloxicam	34	17
Olmesartan Medoxomil	Olmesartan Medoxomil	34	12
Famotidine	Famotidine	33	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	suppressed
Fenofibrate	Fenofibrate	32	12
Ondansetron Hcl	Ondansetron Hcl	30	suppressed
Glipizide	Glipizide	28	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	28	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	28	suppressed
Pregabalin	Pregabalin	28	suppressed
Simvastatin	Simvastatin	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Liothyronine Sodium	Liothyronine Sodium	27	suppressed
Benazepril Hcl	Benazepril Hcl	26	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	25	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Spironolactone	Spironolactone	24	suppressed
Allopurinol	Allopurinol	23	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Mounjaro	Tirzepatide	22	suppressed
Nystatin	Nystatin	21	suppressed
Prednisone	Prednisone	21	17
Valacyclovir	Valacyclovir Hcl	21	11
Dexlansoprazole Dr	Dexlansoprazole	20	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Alendronate Sodium	Alendronate Sodium	19	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Fenofibrate	Fenofibrate,micronized	19	suppressed
Azithromycin	Azithromycin	18	12
Farxiga	Dapagliflozin Propanediol	18	suppressed
Jardiance	Empagliflozin	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Doxepin Hcl	Doxepin Hcl	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Promethazine Hcl	Promethazine Hcl	17	suppressed
Telmisartan	Telmisartan	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Armour Thyroid	Thyroid,pork	16	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Finasteride	Finasteride	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Victoza 2-Pak	Liraglutide	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Verapamil Sr	Verapamil Hcl	14	suppressed
Invokana	Canagliflozin	13	suppressed
Klonopin	Clonazepam	13	suppressed
Prazosin Hcl	Prazosin Hcl	13	suppressed
Victoza 3-Pak	Liraglutide	13	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	12	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Premarin	Estrogens, Conjugated	12	suppressed
Savella	Milnacipran Hcl	12	suppressed
Torsemide	Torsemide	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error